title: Neprilysin inhibitors preserve renal function in heart failure.
authors.affiliation: Clinical Pharmacology and Therapeutics Department, Alfred Hospital, Australia. Electronic address: F.Bodey@alfred.org.au.
authors.forename: Fiona
authors.initials: F
authors.lastname: Bodey
authors.affiliation: Clinical Pharmacology and Therapeutics Department, Alfred Hospital, Australia; CCRE Therapeutics, Monash University, Melbourne, Australia.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Hopper
authors.affiliation: Clinical Pharmacology and Therapeutics Department, Alfred Hospital, Australia; CCRE Therapeutics, Monash University, Melbourne, Australia.
authors.forename: Henry
authors.initials: H
authors.lastname: Krum
mesh_terms: D000613:Aminobutyrates / Q000494:pharmacology / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D004338:Drug Combinations; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000502:physiology*; D015260:Neprilysin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D000068756:Valsartan
chemical_list: D000613:Aminobutyrates; D001713:Biphenyl Compounds; D004338:Drug Combinations; D013777:Tetrazoles; D000068756:Valsartan; D015260:Neprilysin; C549068:sacubitril and valsartan sodium hydrate drug combination
keywords: Heart failure; Neprilysin inhibitors; Renal dysfunction